Literature DB >> 15380723

Development and validation of a liquid chromatography-mass spectrometry method for the quantitation of naltrexone and 6beta-naltrexol in guinea pig plasma.

Satyanarayana Valiveti1, Buchi N Nalluri, Dana C Hammell, Kalpana S Paudel, Audra L Stinchcomb.   

Abstract

A quantitative liquid chromatographic-electrospray ionization mass spectrometry method for the determination of naltrexone and 6beta-naltrexol in guinea pig plasma has been developed and validated using naloxone as an internal standard. A single step precipitation-extraction technique was carried out to extract the plasma samples using acetonitrile:ethyl acetate (1:1, v/v). The chromatographic separation was performed on a C(18) column using a mobile phase consisting of 35:65 (v/v) acetonitrile:2 mM ammonium acetate with 0.01 mM ammonium citrate at a flow rate of 0.25 mL/min. The analyte was detected after positive electrospray ionization using selected ion monitoring (SIM) mode. The mean recoveries for naltrexone, naltrexol, and naloxone were 91.7, 89.3, and 99.0%, respectively. The lower limit of quantification (LLOQ) for naltrexone and 6beta-naltrexol was 1.25 ng/mL, and the limit of detection (LOD) was 0.75 ng/mL. The method was applied to a pharmacokinetic study in order to assess the drug disposition of naltrexone in guinea pigs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15380723     DOI: 10.1016/j.jchromb.2004.08.016

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  4 in total

1.  Diclofenac enables prolonged delivery of naltrexone through microneedle-treated skin.

Authors:  Stan L Banks; Kalpana S Paudel; Nicole K Brogden; Charles D Loftin; Audra L Stinchcomb
Journal:  Pharm Res       Date:  2011-02-08       Impact factor: 4.200

2.  Diclofenac enables unprecedented week-long microneedle-enhanced delivery of a skin impermeable medication in humans.

Authors:  Nicole K Brogden; Stan L Banks; Leslie J Crofford; Audra L Stinchcomb
Journal:  Pharm Res       Date:  2013-06-13       Impact factor: 4.200

3.  In vivo evaluation of a transdermal codrug of 6-beta-naltrexol linked to hydroxybupropion in hairless guinea pigs.

Authors:  Paul K Kiptoo; Kalpana S Paudel; Dana C Hammell; Mohamed O Hamad; Peter A Crooks; Audra L Stinchcomb
Journal:  Eur J Pharm Sci       Date:  2008-01-31       Impact factor: 4.384

4.  Microneedles permit transdermal delivery of a skin-impermeant medication to humans.

Authors:  Daniel P Wermeling; Stan L Banks; David A Hudson; Harvinder S Gill; Jyoti Gupta; Mark R Prausnitz; Audra L Stinchcomb
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-04       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.